Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib

NCT02056080 · clinicaltrials.gov ↗
COMPLETED
Status
111
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

MedSIR